Finally, the authors concluded that miR-100 participates in the development of cervical cancer at least partly through loss of inhibition to target gene PLK1, which probably occurs in a relative late phase of carcinogenesis [37]. The gene discussed is PLK1; the disease is cervical carcinoma.